The cure, or even just an effective treatment, for Alzheimer's disease has remained elusive for decades. Many pharmaceutical companies to date have jumped on the bandwagon for targeting beta amyloid plaques after they develop. Unfortunately, no matter how promising drugs appear in phase 2 results, they fail in phase 3 trials without slowing the progression of this debilitating neurological disease. Now, researchers at the University of Cambridge have discovered the mechanism for the formation of beta amyloid plaques. Can this discovery lead to an effective treatment? It certainly has potential, but developing antibodies to target the process will take many years. Get the details from Fool contributor Maxx Chatsko in the video below.
Is This the Beginning of the End for Alzheimer's?
By Maxx Chatsko – May 29, 2013 at 6:30PM
NYSE: PFE
Pfizer
Market Cap
$138B
Today's Change
-
(0.00%) $0.00
Current Price
$24.29
Price as of October 30, 2025 at 4:00 PM ET
An exciting discovery from the University of Cambridge may hold the key to the world's first effective treatment for Alzheimer's disease.
About the Author
Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.